Alaunos Therapeutics, Inc.

Nasdaq:TCRT

Pharmaceutical Preparations·FORT LAUDERDALE, FL

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K/A	FY 2024	12/31/24	4/30/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

12 shown

Filed	Period
10/10/24	Q3 FY2024	→
11/14/23	Q4 FY2023	→
8/14/23	Q3 FY2023	→
5/10/23	Q2 FY2023	→
3/7/23	Q1 FY2023	→
11/14/22	Q4 FY2022	→
↓

News (8-K)

68 shown

Filed	Type	Description
3/2/26	Other	Other Events	→
1/8/26	Other	Termination of a Material Definitive Agreement	→
12/23/25	Other	Other Events	→
8/20/25	Other	Other Events	→
7/22/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/11/25	424B8	424B8	→
11/7/25	S-3/A	S-3/A	→
10/22/25	S-1	S-1	→
10/2/25	S-3/A	S-3/A	→
9/9/25	S-3/A	S-3/A	→
8/21/25	S-3	S-3	→
↓

Filing History(1005 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13D/A

Mar 5, 2026

0002094682-26-000002

—

643.4 KB

8-K

Mar 2, 2026

0001193125-26-0840848-K

Mar 2, 2026

226.7 KB

SCHEDULE 13D/A

Feb 24, 2026

0002094682-26-000001

—

517.6 KB

Jan 15, 2026

0001193125-26-0141174

Jan 12, 2026

4.6 KB

Jan 15, 2026

0001193125-26-0141164

Jan 12, 2026

6.2 KB

Jan 15, 2026

0001193125-26-0141154

Jan 12, 2026

6.2 KB

8-K

Jan 8, 2026

0001193125-26-0070548-K

Jan 8, 2026

567.3 KB

8-K

Dec 23, 2025

0001193125-25-3311478-K

Dec 17, 2025

213.8 KB

424B8

Dec 11, 2025

0001193125-25-316216424B8

—

332.7 KB

SCHEDULE 13D/A

Dec 5, 2025

0002094682-25-000003

—

310.5 KB

Nov 26, 2025

0001193125-25-3010334

Nov 21, 2025

6.2 KB

Nov 26, 2025

0001193125-25-3010264

Nov 21, 2025

6.2 KB

Nov 26, 2025

0001193125-25-3010254

Nov 21, 2025

4.6 KB

10-Q

Nov 14, 2025

0001193125-25-28298810-Q

Sep 30, 2025

5.5 MB

S-3/A

Nov 7, 2025

0001193125-25-272465S-3/A

—

507.3 KB

SCHEDULE 13D/A

Oct 31, 2025

0002094682-25-000002

—

2.8 MB

SCHEDULE 13D

Oct 30, 2025

0002094682-25-000001

—

2.2 MB

S-1

Oct 22, 2025

0001193125-25-245483S-1

—

617.2 KB

SCHEDULE 13G/A

Oct 16, 2025

0001213900-25-099624

—

6.7 KB

S-3/A

Oct 2, 2025

0001193125-25-227248S-3/A

—

483.0 KB

S-3/A

Sep 9, 2025

0001193125-25-198562S-3/A

—

833.8 KB

SCHEDULE 13D/A

Sep 5, 2025

0001213900-25-085149

—

11.2 KB

SCHEDULE 13G

Sep 4, 2025

0001213900-25-084258

—

8.3 KB

S-3

Aug 21, 2025

0001193125-25-184432S-3

—

744.9 KB

Aug 20, 2025

0000950170-25-1105314

Aug 18, 2025

7.0 KB

25 filings shown

Filed	Form	Description
5/21/25	DEFA14A	DEFA14A	→
5/21/25	DEF 14A	DEF 14A	→
5/9/25	PRE 14A	PRE 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/15/24	PRE 14A	PRE 14A	→
↓

Alaunos Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1005 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/15/26	4	4	→
1/15/26	4	4	→
1/15/26	4	4	→
11/26/25	4	4	→
11/26/25	4	4	→
11/26/25	4	4	→
↓

Filed	Form	Description
3/5/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/24/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
12/5/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/31/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/30/25	SCHEDULE 13D	SCHEDULE 13D	→
10/16/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓